Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Oct;43(5):1971-1987.
doi: 10.1007/s10753-020-01271-4.

Lysophosphatidylinositol, an Endogenous Ligand for G Protein-Coupled Receptor 55, Has Anti-inflammatory Effects in Cultured Microglia

Tomoki Minamihata  1 , Katsura Takano  1 , Mitsuaki Moriyama  2 , Yoichi Nakamura  1
Affiliations

Lysophosphatidylinositol, an Endogenous Ligand for G Protein-Coupled Receptor 55, Has Anti-inflammatory Effects in Cultured Microglia

Tomoki Minamihata et al. Inflammation. 2020 Oct.

Abstract

Lysophosphatidylinositol (LysoPI), an endogenous ligand for G protein-coupled receptor (GPR) 55, has been known to show various functions in several tissues and cells; however, its roles in the central nervous system (CNS) are not well known. In particular, the detailed effects of LysoPI on microglial inflammatory responses remain unknown. Microglia is the immune cell that has important functions in maintaining immune homeostasis of the CNS. In this study, we explored the effects of LysoPI on inflammatory responses using the mouse microglial cell line BV-2, which was stimulated with lipopolysaccharide (LPS), and some results were confirmed also in rat primary microglia. LysoPI was found to reduce LPS-induced nitric oxide (NO) production and inducible NO synthase protein expression without affecting cell viability in BV-2 cells. LysoPI also suppressed intracellular generation of reactive oxygen species both in BV-2 cells and primary microglia and cytokine release in BV-2 cells. In addition, LysoPI treatment decreased phagocytic activity of LPS-stimulated BV-2 cells and primary microglia. The GPR55 antagonist CID16020046 completely inhibited LysoPI-induced downregulation of phagocytosis in BV-2 microglia, but did not affect the LysoPI-induced decrease in NO production. Our results suggest that LysoPI suppresses microglial phagocytosis via a GPR55-dependent pathway and NO production via a GPR55-independent pathway. LysoPI may contribute to neuroprotection in pathological conditions such as brain injury or neurodegenerative diseases, through its suppressive role in the microglial inflammatory response.

Keywords: GPR55; lysophosphatidylinositol; microglia; neuroinflammation; phagocytosis.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Kreutzberg, G.W. 1996. Microglia: a sensor for pathological events in the CNS. Trends in Neurosciences 19: 312–318. https://doi.org/10.1016/0166-2236(96)10049-7 . - DOI - PubMed
    1. Nakamura, Y. 2002. Regulating factors for microglial activation. Biological and Pharmaceutical Bulletin 25: 945–953. https://doi.org/10.1248/bpb.25.945 . - DOI - PubMed
    1. Block, M.L., L. Zecca, and J. Hong. 2007. Microglia-mediated neurotoxicity: uncovering the molecular mechanisms. Nature Reviews Neuroscience 8: 57–69. https://doi.org/10.1038/nrn2038 . - DOI - PubMed
    1. Neniskyte, U., J.J. Neher, and G.C. Brown. 2011. Neuronal death induced by nanomolar amyloid β is mediated by primary phagocytosis of neurons by microglia. Journal of Biological Chemistry 286: 39904–39913. https://doi.org/10.1074/jbc.M111.267583 . - DOI - PubMed
    1. Brown, G.C., and A. Vilalta. 2015. How microglia kill neurons. Brain Research 1628: 288–297. https://doi.org/10.1016/j.brainres.2015.08.031 . - DOI - PubMed

LinkOut - more resources